Literature DB >> 1390952

Schizoaffective disorders with and without onset in the puerperium.

A Rohde1, A Marneros.   

Abstract

The premorbid and sociodemographic features, long-term course and long-term outcome (on average 23.8 resp. 26.8 years after onset of illness) were compared in 30 female schizoaffective patients with onset of their illness during the puerperium and 60 female schizoaffective patients with onset at other times. The majority of premorbid and sociodemographic variables as well as course parameters were similar in the two groups. Most of the few differences (in age at first manifestation, marital state at onset, presence of stable heterosexual relationship before onset, acuteness of onset, presence of life events) are closely connected with the inclusion and exclusion criteria applied for the puerperal disorders (exclusion of patients with preexisting illness or psychiatric symptoms during pregnancy, inclusion only if onset was within 6 weeks of parturition). The puerperal schizoaffective disorders began more frequently with a schizomanic episode and less frequently with a schizodepressive episode than did the non-puerperal schizoaffective disorders, a finding which perhaps reflected the "pathoplastic" role of the puerperium on psychotic disorders. Several significant differences were found regarding the long-term outcome (frequency of persistent alterations, level of global functioning and disability, non-achievement of the expected social development, loss of autarky), confirming earlier findings that puerperal disorders generally have a better outcome than other psychotic disorders.

Entities:  

Mesh:

Year:  1992        PMID: 1390952     DOI: 10.1007/bf02190339

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  25 in total

1.  EPIDEMIOLOGICAL ASPECTS OF PARAPARTUM MENTAL ILLNESS.

Authors:  R S PAFFENBARGER
Journal:  Br J Prev Soc Med       Date:  1964-10

2.  Puerperal mental illness; a follow-up study of 75 cases.

Authors:  M E MARTIN
Journal:  Br Med J       Date:  1958-09-27

3.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

4.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III. Social consequences.

Authors:  A Marneros; E M Steinmeyer; A Deister; A Rohde; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  The prognosis of postpartum mental illness.

Authors:  J E Wilson; P Barglow; W Shipman
Journal:  Compr Psychiatry       Date:  1972 Jul-Aug       Impact factor: 3.735

6.  On the nosology of post-partum psychoses.

Authors:  C Müller
Journal:  Psychopathology       Date:  1985       Impact factor: 1.944

7.  The symptomatology of puerperal illnesses.

Authors:  C Dean; R E Kendell
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319

8.  A follow-up study of severe puerperal psychiatric illness.

Authors:  L da Silva; E C Johnstone
Journal:  Br J Psychiatry       Date:  1981-10       Impact factor: 9.319

9.  A prospective study of postpartum psychoses in a high-risk group. 1. Clinical characteristics of the current postpartum episodes.

Authors:  T F McNeil
Journal:  Acta Psychiatr Scand       Date:  1986-08       Impact factor: 6.392

10.  Measurement of social disability in a schizophrenic patient group. Definition, assessment and outcome over 2 years in a cohort of schizophrenic patients of recent onset.

Authors:  C Schubart; B Krumm; H Biehl; R Schwarz
Journal:  Soc Psychiatry       Date:  1986
View more
  2 in total

Review 1.  [Parent-child treatment in general psychiatry].

Authors:  H Kilian; B Abendschein; B Wagner; C Oelrich
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

2.  Follow-up and family study of postpartum psychoses. Part I: Overview.

Authors:  J Schöpf; B Rust
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.